Skip to main content

and
  1. Article

    Effects of 12 weeks’ treatment with a proton pump inhibitor on insulin secretion, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind prospective placebo-controlled study

    Recent studies suggest that proton pump inhibitor treatment may increase insulin secretion and improve glucose metabolism in type 2 diabetes. In a randomised double-blind prospective placebo-controlled 2 × 2 f...

    K. D. Hove, C. Brøns, K. Færch, S. S. Lund, J. S. Petersen, A. E. Karlsen in Diabetologia (2013)

  2. Article

    Open Access

    Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes

    Gastrin has been implicated in islet growth/neogenesis, and proton pump inhibitors (PPIs) have been shown to increase endogenous gastrin levels in animals and humans. Therefore, we investigated the effect of P...

    T. B. Bödvarsdóttir, K. D. Hove, C. F. Gotfredsen, L. Pridal, A. Vaag in Diabetologia (2010)